CINNARIZINE / DIMENHYDRINATE (ArlevertĀ®)
Clinical Indication
Dizziness in Meniere's disease
Comments
Click on drug name for further details
Date of classification
November 2013
Yellow
Medicines initiated or recommended by a specialist service for prescribing in primary care which do not require initiation or ongoing oversight by the specialist. There are no specific paperwork requirements between provider organisations and a verbal request may be acceptable through advice and guidance as long enough information is provided so that the transfer of care is safe.